Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)
- Citation:
- Breast Cancer Res Treat vol 138 (1) 99-108
- Year:
- 2013
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Meta-Analysis
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- E. A. Perez M. F. Press A. C. Dueck R. B. Jenkins C. Kim B. Chen I. Villalobos S. Paik M. Buyse A. E. Wiktor R. Meyer M. Finnigan J. Zujewski M. Shing H. M. Stern W. L. Lingle M. M. Reinholz D. J. Slamon
- Networks:
- Study
- NCCTG-N9831
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: